CRISPR Therapeutics AG (CRSP) FCF Margin (QoQ) (2016 - 2026)
CRISPR Therapeutics AG (CRSP) FCF Margin (QoQ) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
326,849.00 |
| Dec 31, 2025 |
-124,353.00 |
| Sep 30, 2025 |
325,147.00 |
| Jun 30, 2025 |
-651,947.00 |
| Mar 31, 2025 |
-612,447.00 |
| Dec 31, 2024 |
1.77 Mn |
| Sep 30, 2024 |
82,855.00 |
| Jun 30, 2024 |
-4.03 Mn |
| Mar 31, 2024 |
2.17 Mn |
| Jun 30, 2023 |
-20,220.00 |
| Mar 31, 2023 |
242.66 Mn |
| Dec 31, 2022 |
-233.60 Mn |
| Sep 30, 2022 |
1.13 Mn |
| Jun 30, 2022 |
-8.69 Mn |
| Mar 31, 2022 |
-1.38 Mn |
| Dec 31, 2021 |
846,415.00 |
| Sep 30, 2021 |
-980,576.00 |
| Jun 30, 2021 |
2.04 Mn |
| Mar 31, 2021 |
-72,131.00 |
| Dec 31, 2020 |
3.80 Mn |
